Fennec Pharmaceuticals Inc
NASDAQ:FENC 3:55:26 PM EDT
| Market Cap (Intraday) | 143.66M |
| Current PE | 52.53 |
| Forward PE | 47.73 |
| 2yr Forward PE | 30.88 |
| 10-Day MA | $5.39 |
| 50-Day MA | $5.93 |
| 200-Day MA | $8.41 |
Fennec Pharmaceuticals Inc Stock, NASDAQ:FENC
Research Triangle Park, 68 T.W. Alexander Drive, Durham, North Carolina 27709
United States of America
Phone: +1.919.636.4530
Number of Employees: 29
Description
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.